1. Home
  2. TOL vs NBIX Comparison

TOL vs NBIX Comparison

Compare TOL & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toll Brothers Inc.

TOL

Toll Brothers Inc.

HOLD

Current Price

$147.06

Market Cap

15.7B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$132.87

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOL
NBIX
Founded
1967
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7B
13.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
TOL
NBIX
Price
$147.06
$132.87
Analyst Decision
Buy
Strong Buy
Analyst Count
17
22
Target Price
$164.44
$180.82
AVG Volume (30 Days)
1.1M
950.3K
Earning Date
05-19-2026
05-05-2026
Dividend Yield
0.72%
N/A
EPS Growth
N/A
41.95
EPS
2.19
4.67
Revenue
$7,143,258,000.00
$161,626,000.00
Revenue This Year
N/A
$22.85
Revenue Next Year
$6.01
$10.36
P/E Ratio
$63.47
$27.47
Revenue Growth
N/A
977.51
52 Week Low
$90.78
$98.95
52 Week High
$168.36
$160.18

Technical Indicators

Market Signals
Indicator
TOL
NBIX
Relative Strength Index (RSI) 59.38 54.14
Support Level $128.61 $124.29
Resistance Level $150.45 $136.23
Average True Range (ATR) 3.91 4.21
MACD 1.43 0.12
Stochastic Oscillator 86.26 85.22

Price Performance

Historical Comparison
TOL
NBIX

About TOL Toll Brothers Inc.

Toll Brothers Inc is the luxury homebuilder in the USA, operating in over 60 markets across 24 states. The Fort Washington, Pennsylvania-headquartered homebuilder caters to affluent first-time, move-up, active-adult, and second-homebuyers. Toll Brothers has shifted in recent years to a greater mix of speculative, or "quick move-in" homes. The homebuilder has also expanded its price points, with a greater emphasis on "affordable luxury. Traditional homebuilding accounts for the majority of Toll Brothers' earnings, but the firm also offers ancillary mortgage, title, insurance, and other services.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: